We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

European Patent Office Upholds Angiotech's Patent For Drug-Coated Stents

Law360 (January 24, 2005, 12:00 AM EST) -- The European Patent Office has upheld the validity of Canadian medical device maker Angiotech Pharmaceuticals’ patent on specially coated medical stents, the company said Monday.

The EPO maintained the validity of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.